Beckley Psytech’s Post

View organization page for Beckley Psytech

7,635 followers

How do you progress a psychedelic-based treatment through development and onto patients in need? That's what our Founder and CEO, Cosmo Feilding Mellen, discussed with Brandon Li on the 'Power to the Patients' podcast, where he covered everything from why we're looking at compounds that elicit a short treatment duration to ethics in psychedelic medicine development. Full episode in the comments.

Nicolas Glinsky, PhD

Business Development Manager at WuXi STA, a WuXi AppTec Company / My posts are of my views only and should not reflect on my company.

6mo

I'd be interested to know more 😀

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics